WELCOME

The focus of Savine Therapeutics Pty Ltd (?Savine? or the ?Company?) is to co-develop and partner with existing vaccine programs that are targeting serious diseases where there is a substantial un-met clinical need. Savine is the owner of the proprietary Scrambled Antigen Vaccine (SAVINE) technology which offers licensees three specific competitive advantages (see page entitled ?Competitive Advantages?)..
read more

Overview

SAVINE Constructs

How does SAVINE work?
SAVINE had validated four constructs for nasopharyngeal carcinoma (NPC) and other Epstein Barr virus (EBV) related lymphomas, tuberculosis (TB), HIV, and HCV..   more
read more